Results 231 to 240 of about 55,357 (300)

Development and Validation of the Cheek Smoothness Scale: A Photonumeric Assessment Tool for Cheek Skin Texture

Journal of Cosmetic Dermatology, Volume 25, Issue 4, April 2026.
ABSTRACT Background Changes in cheek skin texture and surface smoothness are prominent features of facial aging and increasingly targeted by modern aesthetic interventions. However, despite rising demand for minimally invasive aesthetic procedures to improve cheek skin quality, validated site‐specific photonumeric assessment tools remain limited.
Hye Sung Han, Beom Joon Kim
wiley   +1 more source

Efficacy of botulinum toxin type A for spasticity management and motor function in children with cerebral palsy: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Front Neurol
Alghadier M, Alsuwayegh A.
europepmc   +1 more source

The ARTIST Post‐Market Study: Evaluating a High G' Hyaluronic Acid (HA) Injectable for Chin Combined With Midface HA Filler Treatments

Journal of Cosmetic Dermatology, Volume 25, Issue 4, April 2026.
ABSTRACT Background A novel hyaluronic acid (HA) injectable (Restylane Shaype, HASHA) with high strength/firmness and enhanced HA concentration, optimized for lower face shaping has been developed. Aims This prospective, 8‐week, multicenter, post‐market study evaluated three treatment algorithms, i.e., the Shayping Technique, for subjects with multiple
Andreas Nikolis, Jason K. Rivers, Nathan Rosen, Felipe Weinberg, Inna Prygova, Torun Bromée   +5 more
wiley   +1 more source

A Pilot Study of Differences in Antibody Responses of Intradermal and Intramuscular Injections of Botulinum Toxin Type A. [PDF]

Dermatol Ther (Heidelb)
Srinoulprasert Y, Sirisuthivoranunt S, Sripatumtong C, Tansit T, Yan C, Apinuntham C, Techapichetvanich T, Eimpunth S, Manuskiatti W, Wanitphakdeedecha R.   +9 more
europepmc   +1 more source

Systematic Review and Meta‐Analysis of Secondary Treatment Failure and Immunogenicity with Botulinum Neurotoxin A in Multiple Indications—Comment on Recommending IncobotulinumtoxinA as First‐Line to Prevent Secondary Treatment Failure [Letter]

European Journal of Neurology, Volume 33, Issue 4, April 2026.
Fabiano Nadson Magacho‐Vieira
wiley   +1 more source

Is Ready‐To‐Use AbobotulinumtoxinA More Effective Than OnabotulinumtoxinA for Glabellar Lines? A Randomized, Controlled, Triple‐Blinded Clinical Trial

Journal of Cosmetic Dermatology, Volume 25, Issue 4, April 2026.
ABSTRACT Background Most commercially available botulinum toxin A (BoNT‐A) formulations are lyophilized or vacuum‐dried powders requiring reconstitution. Recently a ready‐to‐use formulation (RTUaboBoNT‐A) has been introduced. Although its efficacy in reducing glabellar lines has been reported, comparative data with powder onabotulinumtoxinA (OnaBoNT‐A)
Jacqueline Rosa Gonçalves, Ligia Figueiredo Valesan, Ana Claudia Laureano Navarro Shishido, Alfonso Sanchez‐Ayala, Ana Claudia Carbone, Mariana Barbosa Câmara‐Souza, Giancarlo De la Torre Canales   +6 more
wiley   +1 more source

Comparison of the Effectiveness of Greater Occipital Nerve Block and Botulinum Toxin Type A in Chronic Migraine: An Exploratory Pilot Study From a Tertiary Care Centre in a Resource-Limited Setting. [PDF]

Cureus
Singh B, Singla M, Kaushal H, Kaur J, Singh G.   +4 more
europepmc   +1 more source

Treatment of Melasma Targeting Dermal–Epidermal Interactions Utilizing High‐Intensity, High‐Frequency Parallel Ultrasound Beam in Asian Skin

Journal of Cosmetic Dermatology, Volume 25, Issue 4, April 2026.
ABSTRACT Background Melasma is a multifactorial disorder, and while treatments aimed at suppressing melanin production and removing excess melanin have demonstrated some efficacy, no definitive therapy has yet been established. Dermal aging is widely recognized as a contributing factor in melasma, and previous studies have demonstrated that the ...
Kentaro Oku
wiley   +1 more source

New Drugs: Botulinum toxin type A

Australian Prescriber, 1994
openaire   +1 more source

Signal mining of botulinum toxin type A adverse events based on FAERS database and its implications for the treatment of cerebral palsy. [PDF]

Front Hum Neurosci
Wang H, Ma S, Lai J, Huang Y.
europepmc   +1 more source